CDCA2_HUMAN - dbPTM
CDCA2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CDCA2_HUMAN
UniProt AC Q69YH5
Protein Name Cell division cycle-associated protein 2
Gene Name CDCA2
Organism Homo sapiens (Human).
Sequence Length 1023
Subcellular Localization Nucleus . Excluded from the nucleolus. Present in nucleoplasm throughout the G1, S and G2 stages of the cell cycle. During M phase, it becomes diffuse throughout the cell as the nuclear membrane breaks down, and faintly accumulates later on metaphase
Protein Description Regulator of chromosome structure during mitosis required for condensin-depleted chromosomes to retain their compact architecture through anaphase. Acts by mediating the recruitment of phopsphatase PP1-gamma subunit (PPP1CC) to chromatin at anaphase and into the following interphase. At anaphase onset, its association with chromatin targets a pool of PPP1CC to dephosphorylate substrates..
Protein Sequence MDANSKDKPPETKESAMNNAGNASFILGTGKIVTPQKHAELPPNPCTPDTFKSPLNFSTVTVEQLGITPESFVRNSAGKSSSYLKKCRRRSAVGARGSPETNHLIRFIARQQNIKNARKSPLAQDSPSQGSPALYRNVNTLRERISAFQSAFHSIKENEKMTGCLEFSEAGKESEMTDLTRKEGLSACQQSGFPAVLSSKRRRISYQRDSDENLTDAEGKVIGLQIFNIDTDRACAVETSVDLSEISSKLGSTQSGFLVEESLPLSELTETSNALKVADCVVGKGSSDAVSPDTFTAEVSSDAVPDVRSPATPACRRDLPTPKTFVLRSVLKKPSVKMCLESLQEHCNNLYDDDGTHPSLISNLPNCCKEKEAEDEENFEAPAFLNMRKRKRVTFGEDLSPEVFDESLPANTPLRKGGTPVCKKDFSGLSSLLLEQSPVPEPLPQPDFDDKGENLENIEPLQVSFAVLSSPNKSSISETLSGTDTFSSSNNHEKISSPKVGRITRTSNRRNQLVSVVEESVCNLLNTEVQPCKEKKINRRKSQETKCTKRALPKKSQVLKSCRKKKGKGKKSVQKSLYGERDIASKKPLLSPIPELPEVPEMTPSIPSIRRLGSGYFSSNGKLEEVKTPKNPVKRKDLLRHDPDLHMHQGYDKYDVSEFCSYIKSSSSLGNATSDEDPNTNIMNINENKNIPKAKNKSESENEPKAGTDSPVSCASVTEERVASDSPKPALTLQQGQEFSAGGQNAENLCQFFKISPDLNIKCERKDDFLGAAEGKLQCNRLMPNSQKDCHCLGDVLIENTKESKSQSEDLGRKPMESSSVVSCRDRKDRRRSMCYSDGRSLHLEKNGNHTPSSSVGSSVEISLENSELFKDLSDAIEQTFQRRNSETKVRRSTRLQKDLENEGLVWISLPLPSTSQKAKRRTICTFDSSGFESMSPIKETVSSRQKPQMAPPVSDPENSQGPAAGSSDEPGKRRKSFCISTLANTKATSQFKGYRRRSSLNGKGESSLTALERIEHNGERKQ
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6"N6,N6-dimethyllysine"--MDANSKDKPPETK
--CCCCCCCCCCCCH
70.36-
6Methylation--MDANSKDKPPETK
--CCCCCCCCCCCCH
70.36-
13"N6,N6-dimethyllysine"KDKPPETKESAMNNA
CCCCCCCHHHHHHCC
48.27-
13MethylationKDKPPETKESAMNNA
CCCCCCCHHHHHHCC
48.27-
24PhosphorylationMNNAGNASFILGTGK
HHCCCCEEEEECCCC
19.4725850435
34PhosphorylationLGTGKIVTPQKHAEL
ECCCCCCCCCCCCCC
24.3922199227
47PhosphorylationELPPNPCTPDTFKSP
CCCCCCCCCCCCCCC
26.0028985074
50PhosphorylationPNPCTPDTFKSPLNF
CCCCCCCCCCCCCCC
33.8825627689
52MethylationPCTPDTFKSPLNFST
CCCCCCCCCCCCCCE
53.94-
53PhosphorylationCTPDTFKSPLNFSTV
CCCCCCCCCCCCCEE
30.3525159151
59PhosphorylationKSPLNFSTVTVEQLG
CCCCCCCEEEHHHCC
18.9622210691
68PhosphorylationTVEQLGITPESFVRN
EHHHCCCCHHHHHHC
21.1425159151
71PhosphorylationQLGITPESFVRNSAG
HCCCCHHHHHHCCCC
30.1922210691
76PhosphorylationPESFVRNSAGKSSSY
HHHHHHCCCCCCHHH
28.0326055452
79UbiquitinationFVRNSAGKSSSYLKK
HHHCCCCCCHHHHHH
47.05-
80PhosphorylationVRNSAGKSSSYLKKC
HHCCCCCCHHHHHHH
24.4928152594
81PhosphorylationRNSAGKSSSYLKKCR
HCCCCCCHHHHHHHH
26.8728152594
82PhosphorylationNSAGKSSSYLKKCRR
CCCCCCHHHHHHHHH
41.3928152594
83PhosphorylationSAGKSSSYLKKCRRR
CCCCCHHHHHHHHHH
25.2128152594
91PhosphorylationLKKCRRRSAVGARGS
HHHHHHHCCCCCCCC
26.0424732914
96MethylationRRSAVGARGSPETNH
HHCCCCCCCCHHHHH
39.95-
98PhosphorylationSAVGARGSPETNHLI
CCCCCCCCHHHHHHH
17.6330266825
99PhosphorylationAVGARGSPETNHLIR
CCCCCCCHHHHHHHH
56.0818220336
101PhosphorylationGARGSPETNHLIRFI
CCCCCHHHHHHHHHH
31.1830266825
106MethylationPETNHLIRFIARQQN
HHHHHHHHHHHHHHC
24.23-
115AcetylationIARQQNIKNARKSPL
HHHHHCHHHHHHCCC
52.707674181
119AcetylationQNIKNARKSPLAQDS
HCHHHHHHCCCCCCC
54.757674189
119MethylationQNIKNARKSPLAQDS
HCHHHHHHCCCCCCC
54.75-
119UbiquitinationQNIKNARKSPLAQDS
HCHHHHHHCCCCCCC
54.75-
120PhosphorylationNIKNARKSPLAQDSP
CHHHHHHCCCCCCCC
21.4225159151
121PhosphorylationIKNARKSPLAQDSPS
HHHHHHCCCCCCCCC
34.4518669648
126PhosphorylationKSPLAQDSPSQGSPA
HCCCCCCCCCCCCHH
17.8625159151
127PhosphorylationSPLAQDSPSQGSPAL
CCCCCCCCCCCCHHH
38.6718669648
128PhosphorylationPLAQDSPSQGSPALY
CCCCCCCCCCCHHHH
51.6421712546
129PhosphorylationLAQDSPSQGSPALYR
CCCCCCCCCCHHHHH
60.8218669648
131PhosphorylationQDSPSQGSPALYRNV
CCCCCCCCHHHHHCH
10.2025159151
132PhosphorylationDSPSQGSPALYRNVN
CCCCCCCHHHHHCHH
32.8618669648
135PhosphorylationSQGSPALYRNVNTLR
CCCCHHHHHCHHHHH
11.4022199227
146PhosphorylationNTLRERISAFQSAFH
HHHHHHHHHHHHHHH
29.2928555341
154PhosphorylationAFQSAFHSIKENEKM
HHHHHHHHHHHCCCC
28.9728555341
162PhosphorylationIKENEKMTGCLEFSE
HHHCCCCCCEEEHHH
35.4923403867
168PhosphorylationMTGCLEFSEAGKESE
CCCEEEHHHCCCHHH
19.7023403867
182UbiquitinationEMTDLTRKEGLSACQ
HCCHHHHHHHHHHHH
51.39-
186PhosphorylationLTRKEGLSACQQSGF
HHHHHHHHHHHHHCC
37.5428555341
191PhosphorylationGLSACQQSGFPAVLS
HHHHHHHHCCCHHHC
19.2728555341
198PhosphorylationSGFPAVLSSKRRRIS
HCCCHHHCCCCCCCE
27.4922199227
199PhosphorylationGFPAVLSSKRRRISY
CCCHHHCCCCCCCEE
26.4822199227
200AcetylationFPAVLSSKRRRISYQ
CCHHHCCCCCCCEEE
46.6925953088
200UbiquitinationFPAVLSSKRRRISYQ
CCHHHCCCCCCCEEE
46.69-
205PhosphorylationSSKRRRISYQRDSDE
CCCCCCCEEECCCCC
17.2528450419
206PhosphorylationSKRRRISYQRDSDEN
CCCCCCEEECCCCCC
12.7528450419
210PhosphorylationRISYQRDSDENLTDA
CCEEECCCCCCCCCC
49.3525159151
215PhosphorylationRDSDENLTDAEGKVI
CCCCCCCCCCCCCEE
44.7520068231
239PhosphorylationDRACAVETSVDLSEI
CCCEEEEEEEEHHHH
27.7030266825
240PhosphorylationRACAVETSVDLSEIS
CCEEEEEEEEHHHHH
10.5030266825
244PhosphorylationVETSVDLSEISSKLG
EEEEEEHHHHHHHHC
28.5530266825
247PhosphorylationSVDLSEISSKLGSTQ
EEEHHHHHHHHCCCC
19.8530266825
276UbiquitinationTETSNALKVADCVVG
CCCCCHHHHHCEEEC
32.73-
284UbiquitinationVADCVVGKGSSDAVS
HHCEEECCCCCCCCC
43.97-
286PhosphorylationDCVVGKGSSDAVSPD
CEEECCCCCCCCCCC
28.6530278072
287PhosphorylationCVVGKGSSDAVSPDT
EEECCCCCCCCCCCC
37.9530266825
291PhosphorylationKGSSDAVSPDTFTAE
CCCCCCCCCCCEEEE
20.8330266825
292PhosphorylationGSSDAVSPDTFTAEV
CCCCCCCCCCEEEEE
37.7518669648
294PhosphorylationSDAVSPDTFTAEVSS
CCCCCCCCEEEEECC
26.6930266825
296PhosphorylationAVSPDTFTAEVSSDA
CCCCCCEEEEECCCC
24.8130266825
300PhosphorylationDTFTAEVSSDAVPDV
CCEEEEECCCCCCCC
17.6322199227
301PhosphorylationTFTAEVSSDAVPDVR
CEEEEECCCCCCCCC
34.4622199227
309PhosphorylationDAVPDVRSPATPACR
CCCCCCCCCCCHHHC
20.8025159151
310PhosphorylationAVPDVRSPATPACRR
CCCCCCCCCCHHHCC
29.5918669648
312PhosphorylationPDVRSPATPACRRDL
CCCCCCCCHHHCCCC
18.1425159151
313PhosphorylationDVRSPATPACRRDLP
CCCCCCCHHHCCCCC
31.3118669648
321PhosphorylationACRRDLPTPKTFVLR
HHCCCCCCCCCHHHH
44.7224719451
323UbiquitinationRRDLPTPKTFVLRSV
CCCCCCCCCHHHHHH
58.0121890473
324PhosphorylationRDLPTPKTFVLRSVL
CCCCCCCCHHHHHHH
21.85-
324 (in isoform 1)Ubiquitination-21.8521890473
329PhosphorylationPKTFVLRSVLKKPSV
CCCHHHHHHHCCCCH
27.8622617229
335PhosphorylationRSVLKKPSVKMCLES
HHHHCCCCHHHHHHH
43.1617081983
336PhosphorylationSVLKKPSVKMCLESL
HHHCCCCHHHHHHHH
6.5817081983
394PhosphorylationMRKRKRVTFGEDLSP
CCCCCCCCCCCCCCH
29.9228176443
400PhosphorylationVTFGEDLSPEVFDES
CCCCCCCCHHHHCCC
31.1925159151
401PhosphorylationTFGEDLSPEVFDESL
CCCCCCCHHHHCCCC
49.4118669648
407PhosphorylationSPEVFDESLPANTPL
CHHHHCCCCCCCCCC
41.3125159151
408PhosphorylationPEVFDESLPANTPLR
HHHHCCCCCCCCCCC
4.3418669648
412PhosphorylationDESLPANTPLRKGGT
CCCCCCCCCCCCCCC
26.3025159151
413PhosphorylationESLPANTPLRKGGTP
CCCCCCCCCCCCCCC
29.9418669648
424UbiquitinationGGTPVCKKDFSGLSS
CCCCCCCCCCCCHHH
59.90-
427PhosphorylationPVCKKDFSGLSSLLL
CCCCCCCCCHHHHHH
49.2927732954
430PhosphorylationKKDFSGLSSLLLEQS
CCCCCCHHHHHHHCC
23.5927732954
431PhosphorylationKDFSGLSSLLLEQSP
CCCCCHHHHHHHCCC
28.2527732954
437PhosphorylationSSLLLEQSPVPEPLP
HHHHHHCCCCCCCCC
20.6320068231
464PhosphorylationNIEPLQVSFAVLSSP
CCCCEEEEEEEECCC
8.4325850435
469PhosphorylationQVSFAVLSSPNKSSI
EEEEEEECCCCCCCC
36.8325850435
470PhosphorylationVSFAVLSSPNKSSIS
EEEEEECCCCCCCCC
28.4725159151
474PhosphorylationVLSSPNKSSISETLS
EECCCCCCCCCEECC
39.2726074081
475PhosphorylationLSSPNKSSISETLSG
ECCCCCCCCCEECCC
31.5726074081
477PhosphorylationSPNKSSISETLSGTD
CCCCCCCCEECCCCC
26.8626074081
483PhosphorylationISETLSGTDTFSSSN
CCEECCCCCCCCCCC
28.6122468782
488PhosphorylationSGTDTFSSSNNHEKI
CCCCCCCCCCCCCCC
32.6622468782
494UbiquitinationSSSNNHEKISSPKVG
CCCCCCCCCCCCCCC
40.10-
496PhosphorylationSNNHEKISSPKVGRI
CCCCCCCCCCCCCEE
52.2124719451
497PhosphorylationNNHEKISSPKVGRIT
CCCCCCCCCCCCEEE
32.0120860994
507PhosphorylationVGRITRTSNRRNQLV
CCEEEECCCCCCHHH
25.67-
556PhosphorylationKRALPKKSQVLKSCR
HHHCCHHHHHHHHHH
31.4820068231
561PhosphorylationKKSQVLKSCRKKKGK
HHHHHHHHHHHHCCC
18.2620068231
575AcetylationKGKKSVQKSLYGERD
CCCHHHHHHHHCCCC
40.0325953088
575UbiquitinationKGKKSVQKSLYGERD
CCCHHHHHHHHCCCC
40.03-
576PhosphorylationGKKSVQKSLYGERDI
CCHHHHHHHHCCCCC
15.1028348404
578PhosphorylationKSVQKSLYGERDIAS
HHHHHHHHCCCCCCC
24.8328348404
591PhosphorylationASKKPLLSPIPELPE
CCCCCCCCCCCCCCC
28.5929255136
592PhosphorylationSKKPLLSPIPELPEV
CCCCCCCCCCCCCCC
46.2318669648
603PhosphorylationLPEVPEMTPSIPSIR
CCCCCCCCCCCHHHH
16.5425159151
604PhosphorylationPEVPEMTPSIPSIRR
CCCCCCCCCCHHHHC
29.0218669648
608PhosphorylationEMTPSIPSIRRLGSG
CCCCCCHHHHCCCCC
27.3625159151
614PhosphorylationPSIRRLGSGYFSSNG
HHHHCCCCCCCCCCC
34.6125159151
616PhosphorylationIRRLGSGYFSSNGKL
HHCCCCCCCCCCCCE
11.2829214152
618PhosphorylationRLGSGYFSSNGKLEE
CCCCCCCCCCCCEEE
17.8925159151
619PhosphorylationLGSGYFSSNGKLEEV
CCCCCCCCCCCEEEC
39.4425627689
622SumoylationGYFSSNGKLEEVKTP
CCCCCCCCEEECCCC
57.91-
622AcetylationGYFSSNGKLEEVKTP
CCCCCCCCEEECCCC
57.9120167786
622SumoylationGYFSSNGKLEEVKTP
CCCCCCCCEEECCCC
57.91-
627AcetylationNGKLEEVKTPKNPVK
CCCEEECCCCCCCCC
63.4920167786
628PhosphorylationGKLEEVKTPKNPVKR
CCEEECCCCCCCCCH
44.6729214152
661PhosphorylationYDVSEFCSYIKSSSS
CCHHHHHHHHHCCCC
34.9028555341
668PhosphorylationSYIKSSSSLGNATSD
HHHHCCCCCCCCCCC
42.0928555341
673PhosphorylationSSSLGNATSDEDPNT
CCCCCCCCCCCCCCC
40.4825627689
674PhosphorylationSSLGNATSDEDPNTN
CCCCCCCCCCCCCCC
36.2725627689
708PhosphorylationENEPKAGTDSPVSCA
CCCCCCCCCCCCCCC
37.8629255136
710PhosphorylationEPKAGTDSPVSCASV
CCCCCCCCCCCCCCC
27.3429255136
713PhosphorylationAGTDSPVSCASVTEE
CCCCCCCCCCCCCCH
13.8321815630
716PhosphorylationDSPVSCASVTEERVA
CCCCCCCCCCCHHCC
33.6224732914
718PhosphorylationPVSCASVTEERVASD
CCCCCCCCCHHCCCC
29.6324732914
724PhosphorylationVTEERVASDSPKPAL
CCCHHCCCCCCCCCE
35.4530266825
726PhosphorylationEERVASDSPKPALTL
CHHCCCCCCCCCEEE
32.1230266825
727PhosphorylationERVASDSPKPALTLQ
HHCCCCCCCCCEEEC
52.2018669648
732PhosphorylationDSPKPALTLQQGQEF
CCCCCCEEECCCCEE
25.3230266825
740PhosphorylationLQQGQEFSAGGQNAE
ECCCCEECCCCCCHH
25.8330266825
756PhosphorylationLCQFFKISPDLNIKC
HHHHHHCCCCCCCEE
16.9823401153
757PhosphorylationCQFFKISPDLNIKCE
HHHHHCCCCCCCEEE
54.2918669648
762SumoylationISPDLNIKCERKDDF
CCCCCCCEEEECCCH
29.04-
762SumoylationISPDLNIKCERKDDF
CCCCCCCEEEECCCH
29.0428112733
766UbiquitinationLNIKCERKDDFLGAA
CCCEEEECCCHHHHH
39.08-
776UbiquitinationFLGAAEGKLQCNRLM
HHHHHCCCEECCCCC
27.22-
806PhosphorylationENTKESKSQSEDLGR
HCCCCCHHCCHHHCC
48.4924719451
808PhosphorylationTKESKSQSEDLGRKP
CCCCHHCCHHHCCCC
39.9222210691
813MethylationSQSEDLGRKPMESSS
HCCHHHCCCCCCCCC
47.40-
814AcetylationQSEDLGRKPMESSSV
CCHHHCCCCCCCCCC
47.0926051181
818PhosphorylationLGRKPMESSSVVSCR
HCCCCCCCCCCEECC
22.9728555341
820PhosphorylationRKPMESSSVVSCRDR
CCCCCCCCCEECCCC
35.5028555341
833PhosphorylationDRKDRRRSMCYSDGR
CCCCCCCCEECCCCC
16.0525262027
837PhosphorylationRRRSMCYSDGRSLHL
CCCCEECCCCCEEEE
28.7623882029
841PhosphorylationMCYSDGRSLHLEKNG
EECCCCCEEEEEECC
26.1823882029
851PhosphorylationLEKNGNHTPSSSVGS
EEECCCCCCCCCCCC
28.9425627689
853PhosphorylationKNGNHTPSSSVGSSV
ECCCCCCCCCCCCEE
36.0825627689
854PhosphorylationNGNHTPSSSVGSSVE
CCCCCCCCCCCCEEE
30.1925627689
855PhosphorylationGNHTPSSSVGSSVEI
CCCCCCCCCCCEEEE
34.5325627689
874PhosphorylationSELFKDLSDAIEQTF
CHHHHHHHHHHHHHH
34.8221406692
880PhosphorylationLSDAIEQTFQRRNSE
HHHHHHHHHHHHCCH
14.6723882029
886PhosphorylationQTFQRRNSETKVRRS
HHHHHHCCHHHHHHH
44.8523882029
888PhosphorylationFQRRNSETKVRRSTR
HHHHCCHHHHHHHHH
34.3623882029
893PhosphorylationSETKVRRSTRLQKDL
CHHHHHHHHHCHHHH
13.81-
923PhosphorylationSQKAKRRTICTFDSS
CHHHCCCEEEEECCC
25.1624732914
926PhosphorylationAKRRTICTFDSSGFE
HCCCEEEEECCCCCC
26.9924732914
929PhosphorylationRTICTFDSSGFESMS
CEEEEECCCCCCCCC
28.3330266825
930PhosphorylationTICTFDSSGFESMSP
EEEEECCCCCCCCCC
49.7123401153
934PhosphorylationFDSSGFESMSPIKET
ECCCCCCCCCCCHHH
23.4630266825
936PhosphorylationSSGFESMSPIKETVS
CCCCCCCCCCHHHHC
32.5229255136
941PhosphorylationSMSPIKETVSSRQKP
CCCCCHHHHCCCCCC
22.2330266825
943PhosphorylationSPIKETVSSRQKPQM
CCCHHHHCCCCCCCC
27.5030266825
944PhosphorylationPIKETVSSRQKPQMA
CCHHHHCCCCCCCCC
34.1030266825
955PhosphorylationPQMAPPVSDPENSQG
CCCCCCCCCCCCCCC
53.9025159151
960PhosphorylationPVSDPENSQGPAAGS
CCCCCCCCCCCCCCC
34.5525159151
967PhosphorylationSQGPAAGSSDEPGKR
CCCCCCCCCCCCCCC
29.8627690223
968PhosphorylationQGPAAGSSDEPGKRR
CCCCCCCCCCCCCCC
45.1127690223
973AcetylationGSSDEPGKRRKSFCI
CCCCCCCCCCCCEEE
60.8026051181
977PhosphorylationEPGKRRKSFCISTLA
CCCCCCCCEEEHHHC
24.4423401153
981PhosphorylationRRKSFCISTLANTKA
CCCCEEEHHHCCCCC
20.6726552605
982PhosphorylationRKSFCISTLANTKAT
CCCEEEHHHCCCCCC
15.2426552605
986PhosphorylationCISTLANTKATSQFK
EEHHHCCCCCCHHCC
19.2226552605
999PhosphorylationFKGYRRRSSLNGKGE
CCCCCCCHHCCCCCH
37.0520873877
1000PhosphorylationKGYRRRSSLNGKGES
CCCCCCHHCCCCCHH
24.8423401153
1004AcetylationRRSSLNGKGESSLTA
CCHHCCCCCHHHHHH
59.4326051181
1007PhosphorylationSLNGKGESSLTALER
HCCCCCHHHHHHHHH
39.0428111955
1008PhosphorylationLNGKGESSLTALERI
CCCCCHHHHHHHHHH
25.9928111955
1010PhosphorylationGKGESSLTALERIEH
CCCHHHHHHHHHHHH
31.0120873877

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
412TPhosphorylationKinaseCDK1P06493
PSP
893SPhosphorylationKinaseAURKBQ96GD4
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CDCA2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CDCA2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of CDCA2_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CDCA2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-400 AND THR-412, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-120; SER-126; SER-128;SER-131; SER-291; SER-309; THR-312; SER-400; SER-407; THR-412;SER-591; THR-603; SER-726 AND SER-756, AND MASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98 AND SER-210, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98, AND MASSSPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-291, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-335 AND SER-400, ANDMASS SPECTROMETRY.

TOP